Ohio State University, U.S.; Recent findings from Ohio State University, U.S., illuminate medical re...
Ohio State University, U.S.; Recent findings from Ohio State University, U.S., illuminate medical research
About this item
Full title
Ohio State University, U.S.; Recent findings from Ohio State University, U.S., illuminate medical research
Publisher
Atlanta: NewsRx
Journal title
Science Letter, 2007, p.5024
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
Moreover, agonist pretreatment converts the neutral antagonists naloxone and naltrexone into inverse agonists, suppressing basal signaling, whereas analogs with reduced C6-position, e.g., 6beta- naltrexol, remain neutral antagonists at MOR under any condition. This study compares the regulation of basal signaling of MOR, delta- (DOR), and kappa-(KO...
Alternative Titles
Full title
Ohio State University, U.S.; Recent findings from Ohio State University, U.S., illuminate medical research
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_209121485
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_209121485
Other Identifiers
ISSN
1538-9111
E-ISSN
1538-9162
How to access this item
Log in as a Library member
